IN2014MN02418A - - Google Patents

Download PDF

Info

Publication number
IN2014MN02418A
IN2014MN02418A IN2418MUN2014A IN2014MN02418A IN 2014MN02418 A IN2014MN02418 A IN 2014MN02418A IN 2418MUN2014 A IN2418MUN2014 A IN 2418MUN2014A IN 2014MN02418 A IN2014MN02418 A IN 2014MN02418A
Authority
IN
India
Prior art keywords
methods
breast cancer
subject
gene expression
evaluating
Prior art date
Application number
Other languages
English (en)
Inventor
Sean M Ferree
James Justin Storhoff
Joel S Parker
Charles M Perou
Matthew J Ellis
Philip S Bernard
Torsten O Nielsen
Original Assignee
Nanostring Technologies Inc
Univ North Carolina
Univ Utah Res Found
British Columbia Cancer Agency
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanostring Technologies Inc, Univ North Carolina, Univ Utah Res Found, British Columbia Cancer Agency, Univ Washington filed Critical Nanostring Technologies Inc
Publication of IN2014MN02418A publication Critical patent/IN2014MN02418A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IN2418MUN2014 2012-05-22 2013-05-22 IN2014MN02418A (mo)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261650209P 2012-05-22 2012-05-22
US201361753673P 2013-01-17 2013-01-17
PCT/US2013/042157 WO2013177245A2 (en) 2012-05-22 2013-05-22 Nano46 genes and methods to predict breast cancer outcome

Publications (1)

Publication Number Publication Date
IN2014MN02418A true IN2014MN02418A (mo) 2015-08-14

Family

ID=49624503

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2418MUN2014 IN2014MN02418A (mo) 2012-05-22 2013-05-22

Country Status (12)

Country Link
US (3) US20130337444A1 (mo)
EP (1) EP2852689B1 (mo)
JP (1) JP6325530B2 (mo)
CN (2) CN104704128A (mo)
AU (1) AU2013266419B2 (mo)
BR (1) BR112014029300A2 (mo)
CA (1) CA2874492C (mo)
ES (1) ES2763931T3 (mo)
IL (1) IL235795B (mo)
IN (1) IN2014MN02418A (mo)
MX (1) MX369628B (mo)
WO (1) WO2013177245A2 (mo)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009158143A1 (en) 2008-05-30 2009-12-30 The University Of North Carolina At Chapel Hill Gene expression profiles to predict breast cancer outcomes
AU2012229123B2 (en) 2011-03-15 2017-02-02 British Columbia Cancer Agency Branch Methods of treating breast cancer with anthracycline therapy
GB201106254D0 (en) 2011-04-13 2011-05-25 Frisen Jonas Method and product
JP6144695B2 (ja) 2011-11-30 2017-06-07 ユニバーシティー オブ ノースカロライナ アット チャペル ヒル タキサン療法を用いて乳癌を処置する方法
DK3511423T4 (da) 2012-10-17 2024-07-29 Spatial Transcriptomics Ab Fremgangsmåder og produkt til optimering af lokaliseret eller rumlig detektion af genekspression i en vævsprøve
AU2014265623A1 (en) * 2013-05-13 2015-11-26 Nanostring Technologies, Inc. Methods to predict risk of recurrence in node-positive early breast cancer
CN118240918A (zh) 2013-06-25 2024-06-25 普罗格诺西斯生物科学公司 采用微流控装置的空间编码生物分析
CA2923166A1 (en) * 2013-09-09 2015-03-12 British Columbia Cancer Agency Branch Methods and kits for predicting outcome and methods and kits for treating breast cancer with radiation therapy
JP6674951B2 (ja) 2014-11-21 2020-04-01 ナノストリング テクノロジーズ,インコーポレイティド 酵素不要及び増幅不要の配列決定
SG11201704177SA (en) * 2014-11-24 2017-06-29 Nanostring Technologies Inc Methods and apparatuses for gene purification and imaging
US20160160293A1 (en) * 2014-12-09 2016-06-09 King's College London Breast cancer treatment with taxane therapy
EP3280820B1 (en) 2015-04-10 2019-06-26 Spatial Transcriptomics AB Spatially distinguished, multiplex nucleic acid analysis of biological specimens
CN107850599B (zh) * 2015-07-23 2021-02-09 新加坡国立大学 Wbp2与her2作为共预后因子对患者分层以进行治疗
US20170327876A1 (en) 2016-05-16 2017-11-16 Nanostring Technologies, Inc. Methods for detecting target nucleic acids in a sample
US11352667B2 (en) 2016-06-21 2022-06-07 10X Genomics, Inc. Nucleic acid sequencing
WO2018074865A2 (ko) * 2016-10-21 2018-04-26 서울대학교병원 유방암 예후 예측용 조성물 및 방법
JP6730525B2 (ja) 2016-11-21 2020-07-29 ナノストリング テクノロジーズ,インコーポレイティド 化学組成物とそれを利用する方法
KR101950717B1 (ko) * 2016-11-23 2019-02-21 주식회사 젠큐릭스 유방암 환자의 화학치료 유용성 예측 방법
WO2018144782A1 (en) * 2017-02-01 2018-08-09 The Translational Genomics Research Institute Methods of detecting somatic and germline variants in impure tumors
US11597965B2 (en) 2017-10-06 2023-03-07 10X Genomics, Inc. RNA templated ligation
KR102071491B1 (ko) * 2017-11-10 2020-01-30 주식회사 디시젠 차세대 염기서열분석을 이용한 기계학습 기반 유방암 예후 예측 방법 및 예측 시스템
SG11202011274YA (en) 2018-05-14 2020-12-30 Nanostring Technologies Inc Chemical compositions and methods of using same
US20210371936A1 (en) * 2018-11-05 2021-12-02 Biontech Diagnostics Gmbh Predictive methods in breast cancer
CN119351523A (zh) 2019-05-31 2025-01-24 10X基因组学有限公司 检测目标核酸分子的方法
JP7352937B2 (ja) * 2019-07-19 2023-09-29 公立大学法人福島県立医科大学 乳癌のサブタイプを鑑別又は分類するための鑑別マーカー遺伝子セット、方法およびキット
GB201919032D0 (en) 2019-12-20 2020-02-05 Cartana Ab Method of detecting an analyte
WO2021168287A1 (en) 2020-02-21 2021-08-26 10X Genomics, Inc. Methods and compositions for integrated in situ spatial assay
US12209273B2 (en) 2020-06-12 2025-01-28 10X Genomics, Inc. Nucleic acid assays using click chemistry bioconjugation
EP3945136A1 (en) * 2020-07-28 2022-02-02 Hospital Clínic de Barcelona In vitro method for the prognosis of patients suffering from her2-positive breast cancer
US12297499B2 (en) 2020-08-17 2025-05-13 10X Genomics, Inc. Multicomponent nucleic acid probes for sample analysis
US12060603B2 (en) 2021-01-19 2024-08-13 10X Genomics, Inc. Methods for internally controlled in situ assays using padlock probes
JP2024543736A (ja) * 2021-12-20 2024-11-22 リヴィール ゲノミクス エセ.エレ HER2陽性乳癌を患う患者の予後診断を行うin vitro方法の開発及び検証
CN117965734B (zh) * 2024-02-02 2024-09-24 奥明星程(杭州)生物科技有限公司 一种用于检测硬纤维瘤的基因标志物、试剂盒、检测方法及应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
CA2118806A1 (en) 1991-09-18 1993-04-01 William J. Dower Method of synthesizing diverse collections of oligomers
US5384261A (en) 1991-11-22 1995-01-24 Affymax Technologies N.V. Very large scale immobilized polymer synthesis using mechanically directed flow paths
JP3939338B2 (ja) 1991-11-22 2007-07-04 アフィメトリックス, インコーポレイテッド ポリマー合成に対する組合わせの戦略
US5856174A (en) 1995-06-29 1999-01-05 Affymetrix, Inc. Integrated nucleic acid diagnostic device
EP0880598A4 (en) 1996-01-23 2005-02-23 Affymetrix Inc RAPID EVALUATION OF NUCLEIC ACID ABUNDANCE DIFFERENCE, WITH A HIGH-DENSITY OLIGONUCLEOTIDE SYSTEM
DE69829402T2 (de) 1997-10-31 2006-04-13 Affymetrix, Inc. (a Delaware Corp.), Santa Clara Expressionsprofile in adulten und fötalen organen
US6020135A (en) 1998-03-27 2000-02-01 Affymetrix, Inc. P53-regulated genes
US6750015B2 (en) * 2000-06-28 2004-06-15 Kathryn B. Horwitz Progesterone receptor-regulated gene expression and methods related thereto
US20020168639A1 (en) * 2000-09-22 2002-11-14 Muraca Patrick J. Profile array substrates
AU2004283068B2 (en) * 2003-06-24 2010-03-18 Genomic Health, Inc. Prediction of likelihood of cancer recurrence
EP2469439A2 (en) * 2003-09-29 2012-06-27 Pathwork Diagnostics, Inc. Systems and methods for detecting biological features
US20080032293A1 (en) 2004-07-15 2008-02-07 The University Of North Carolina At Chapel Hill Housekeeping Genes And Methods For Identifying Same
CN101057144A (zh) * 2004-09-22 2007-10-17 三路影像公司 用于评价乳腺癌预后的方法和组合物
US20090299640A1 (en) 2005-11-23 2009-12-03 University Of Utah Research Foundation Methods and Compositions Involving Intrinsic Genes
AU2006330834B2 (en) 2005-12-23 2013-09-12 Bruker Spatial Biology, Inc. Compositions comprising oriented, immobilized macromolecules and methods for their preparation
WO2007076128A2 (en) * 2005-12-23 2007-07-05 Nanostring Technologies, Inc. Nanoreporters and methods of manufacturing and use thereof
AU2008237018B2 (en) 2007-04-10 2014-04-03 Bruker Spatial Biology, Inc. Methods and computer systems for identifying target-specific sequences for use in nanoreporters
WO2008150512A2 (en) * 2007-06-04 2008-12-11 University Of Louisville Research Foundation, Inc. Methods for identifying an increased likelihood of recurrence of breast cancer
CA2698569A1 (en) * 2007-09-06 2009-09-03 Mark G. Erlander Tumor grading and cancer prognosis
WO2009158143A1 (en) 2008-05-30 2009-12-30 The University Of North Carolina At Chapel Hill Gene expression profiles to predict breast cancer outcomes
AU2009281836B2 (en) 2008-08-14 2015-02-19 Bruker Spatial Biology, Inc. Stable nanoreporters
PT2553118E (pt) * 2010-03-31 2014-12-17 Sividon Diagnostics Gmbh Método para previsão da recorrência de cancro da mama em tratamento endócrino

Also Published As

Publication number Publication date
IL235795A0 (en) 2015-01-29
EP2852689A2 (en) 2015-04-01
JP6325530B2 (ja) 2018-05-16
CA2874492C (en) 2021-10-19
MX369628B (es) 2019-11-14
AU2013266419B2 (en) 2018-09-27
AU2013266419A1 (en) 2014-12-11
US20230272476A1 (en) 2023-08-31
EP2852689B1 (en) 2019-12-11
WO2013177245A2 (en) 2013-11-28
US20200332368A1 (en) 2020-10-22
EP2852689A4 (en) 2016-05-11
MX2014014275A (es) 2015-07-06
IL235795B (en) 2020-02-27
WO2013177245A3 (en) 2015-01-29
CA2874492A1 (en) 2013-11-28
ES2763931T3 (es) 2020-06-01
CN111500718A (zh) 2020-08-07
CN104704128A (zh) 2015-06-10
BR112014029300A2 (pt) 2017-07-25
JP2015518724A (ja) 2015-07-06
US20130337444A1 (en) 2013-12-19

Similar Documents

Publication Publication Date Title
IN2014MN02418A (mo)
CY1114993T1 (el) Προφιλ εκφρασης γονιδιου για να προβλεπονται εκβασεις καρκινου μαστου
MX2019007814A (es) Algoritmo de perfil de expresion genica y prueba para determinar la prognosis de cancer de prostata.
EP2663656A1 (en) Genetic variants as markers for use in urinary bladder cancer risk assessment, diagnosis, prognosis and treatment
WO2013006443A3 (en) Discovery of a somatic mutation in myd88 gene in lymphoplasmacytic lymphoma
EA201370063A1 (ru) Фосфолипидом рака
NZ709167A (en) Compositions and methods for diagnosing thyroid tumors
NZ599194A (en) Methods to predict clinical outcome of cancer
NZ621638A (en) Dna methylation in colorectal and breast cancer diagnostic methods
PH12014502410A1 (en) Breast cancer prognosis, prediction of progesterone receptor subtype and|prediction of response to antiprogestin treatment based on gene expression
HK1222888A1 (zh) 预测在淋巴结阳性早期乳癌复发风险的方法
MX2013008252A (es) Firma de pronostico para la recurrencia de cancer colorrectal.
NZ729773A (en) Biomarkers for disease progression in melanoma
BR112015022977A2 (pt) métodos para predição de risco de metástase em melanoma cutâneo
RU2010149541A (ru) Способ прогнозирования развития метаболического синдрома у пациента с абдоминальным ожирением
Eapen Relapsed acute lymphoblastic leukemia: Is it crucial to achieve molecular remission prior to transplant?
MX2017004816A (es) Métodos para predecir resultados clínicos en sujetos afectados con colitis ulcerosa.
RU2012142904A (ru) Способ прогнозирования риска развития псориаза и псориатического артрита
HK1199097A1 (zh) 用於癌症治疗的预测物
UA108260U (uk) Спосіб прогнозування розвитку остеопорозу
UA95616U (uk) Спосіб прогнозування зрощення перелому
UA59264U (ru) Способ прогнозирования индивидуальной склонности к развитию преэклампсии у беременных
Brennan Quantifying Biomarker Risks and Benefits
Gonzalez-Angulo Putting Genomics into Clinical Practice
Sotiriou et al. Gene Expression Profiling of Breast Cancer: Past and Future